Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-06-27T03:58:27.507Z Has data issue: false hasContentIssue false
  • English
  • Français

Occipital Stimulation for Chronic Migraine: Patient Selection and Complications

Published online by Cambridge University Press:  02 December 2014

Zelma H. T. Kiss  and
Werner J. Becker
Zelma H. T. Kiss*
Affiliation:
Division of Neurosurgery, University of Calgary, Calgary, Alberta, Canada
Werner J. Becker
Affiliation:
Neurology, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
*
Room 1AC58, HRIC, 3280 Hospital Drive NW, Calgary, Alberta, T2N 4N1, Canada. Email: zkiss@ucalgary.ca
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Chronic migraine is a significant cause of disability world-wide and occipital region stimulation (OS) has been proposed to treat it. While participating in an industry-sponsored pilot trial of OS, we aimed to collect data regarding our surgical complications and long term usage of OS in our chronic migraine patients.

Methods:

Ten patients (8 female, median age 46.5 years) were enrolled based on criteria established by the sponsoring company, screened in the headache clinic, and followed for a median of 33 months. We did not access data collected by industry for this report and instead collected our own data prospectively, including predominant location of headache, location of paresthesia evoked by OS, and complications.

Results:

Adverse events included three possible early infections requiring antibiotics but not hardware removal, one late implantable pulse generator erosion requiring removal, one generator malfunction requiring revision, and loss of paresthetic coverage requiring four revisions in four patients. Two patients experienced new symptoms requiring psychiatric intervention. Five patients had no benefit and have been explanted. Of those who remain using their device, the proportion of their pre-operative pain located in the occipital region was 0.62 ± 0.14, whereas in those patients who have been explanted, the proportion was 0.31 ± 0.18 (t = 3.15, p=0.01).

Conclusions:

Complication rates with OS are higher than those seen with other stimulation techniques, despite identical hardware and similar surgery. The location of migraine pain did predict outcome, and suggests that only those with primarily occipital region headache are candidates for this therapy.

Résumé

RÉSUMÉContexte:

La migraine chronique est une cause importante d'invalidité à l'échelle mondiale et la stimulation de la région occipitale (SO) a été proposée comme traitement de cette maladie. Lors de notre participation à un projet pilote sur la SO, commandité par l'industrie, nous avons recueilli des données sur les complications chirurgicales que nous avons observées et sur l'utilisation à long terme de la SO chez nos patients atteints de migraine chronique.

Méthode:

Dix patients dépistés à notre clinique de la céphalée, qui satisfaisaient aux critères de sélection déterminés par le commanditaire, ont été inclus dans l'étude dont 8 femmes et dont l'âge moyen était de 46,5 ans. La durée médiane du suivi a été de 33 mois. Nous n'avons pas eu recours aux données recueillies par le commanditaire pour effectuer cette étude. Nous avons plutôt recueilli nos propres données de façon prospective, dont la région prédominante de la céphalée, l'endroit des paresthésies provoquées par la SO et les complications de l'intervention.

Résultats:

Parmi les incidents thérapeutiques, nous avons noté 3 infections précoces ayant nécessité l'administration d'antibiotiques sans retrait de l'appareillage, une érosion tardive du neurostimulateur implantable ayant nécessité son retrait, un dysfonctionnement du neurostimulateur ayant nécessité une révision et la perte de la couverture paresthésique ayant nécessité 4 révisions chez 4 patients. Deux patients ont présenté de nouveaux symptômes qui ont nécessité une intervention psychiatrique. Cinq patients n'ont pas éprouvé de bénéfice et leur dispositif a été retiré. Chez ceux dont le dispositif est encore en place, la proportion de la douleur préopératoire localisée à la région occipitale était de 0,62 ± 0,14, alors que chez les patients explantés, la proportion était de 0,31 ± 0,18 (t = 3,15; p = 0,01).

Conclusions:

Les taux de complications de la SO sont plus élevés que ceux observés avec d'autres techniques de stimulation, malgré un appareillage et une chirurgie similaires. La localisation de la douleur migraineuse prédisait le résultat thérapeutique, ce qui suggère que seulement ceux qui ont une céphalée principalement occipitale sont des candidats à ce traitement.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 39 , Issue 6 , November 2012 , pp. 807 - 812
Copyright
Copyright © The Canadian Journal of Neurological 2012

References

1. Andlin-Sobocki, P, Jonsson, B, Wittchen, HU, Olesen, J. Cost of disorders of the brain in Europe. Eur J Neurol. 2005; 12(Suppl 1): 1–27.Google Scholar
2. Leonardi, M, Steiner, TJ, Scher, AT, Lipton, RB. The global burden of migraine: measuring disability in headache disorders with WHO’s Classification of Functioning, Disability and Health (ICF). J Headache Pain. 2005; 6(6): 429–40.Google Scholar
3. Olesen, J, Bousser, MG, Diener, HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006; 26(6): 742–6.Google Scholar
4. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004; 24(Suppl 1): 9–160.Google Scholar
5. Weiner, RL, Reed, KL. Peripheral stimulation for the control of intractable occipital neuralgia. Neuromodulation. 1999; 2(3): 217–21.Google Scholar
6. Bartsch, T, Paemeleire, K, Goadsby, PJ. Neurostimulation approaches to primary headache disorders. Curr Opin Neurol. 2009; 22(3): 262–8.Google Scholar
7. Paemeleire, K, Van Buyten, JP, Van, BM, et al. Phenotype of patients responsive to occipital nerve stimulation for refractory head pain. Cephalalgia. 2010; 30(6): 662–73.Google Scholar
8. Trentman, TL, Rosenfeld, DM, Vargas, BB, Schwedt, TJ, Zimmerman, RS, Dodick, DW. Greater occipital nerve stimulation via the Bion microstimulator: implantation technique and stimulation parameters. Clinical trial: NCT00205894. Pain Physician. 2009; 12(3): 621–8.Google Scholar
9. Schwedt, TJ, Dodick, DW, Hentz, J, Trentman, TL, Zimmerman, RS. Occipital nerve stimulation for chronic headache-long-term safety and efficacy. Cephalalgia. 2007; 27(2): 153–7.Google Scholar
10. Saper, JR, Dodick, DW, Silberstein, SD, McCarville, S, Sun, M, Goadsby, PJ. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2011; 31(3): 271–85.Google Scholar
11. Lipton, RB, Goadsby, PJ, Cady, RK, et al. PRISM study: Occipital nerve stimulation for treatment refractory migraine. Cephalalgia. 2009; 29(Suppl 1): 30 (Abstract).Google Scholar
12. Silberstein, SD, Dodick, DW, Saper, JR, et al. The safety and efficacy of peripheral nerve stimulation of the occipital nerve for the management of chronic migraine. Cephalalgia. 2011; 31(Suppl 1): 117 (Abstract).Google Scholar
13. Burchiel, KJ, Anderson, VC, Brown, FD, et al. Prospective, multicenter study of spinal cord stimulation for relief of chronic back and extremity pain. Spine. 1996; 21(23): 2786–94.Google Scholar
14. Kumar, K, Taylor, RS, Jacques, L, et al. Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain. 2007; 132(1–2): 179–88.Google Scholar
15. Kemler, MA, Barendse, GA, van Kleef, M, et al. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med. 2000; 343(9): 618–24.Google Scholar
16. Burns, B, Watkins, L, Goadsby, PJ. Treatment of hemicrania continua by occipital nerve stimulation with a bion device: long-term follow-up of a crossover study. Lancet Neurol. 2008; 7(11): 1001–12.Google Scholar
17. Ubbink, DT, Vermeulen, H, Spincemaille, GH, Gersbach, PA, Berg, P, Amann, W. Systematic review and meta-analysis of controlled trials assessing spinal cord stimulation for inoperable critical leg ischaemia. Br J Surg. 2004; 91(8): 948–55.Google Scholar
18. Trentman, TL, Slavin, KV, Freeman, JA, Zimmerman, RS. Occipital nerve stimulator placement via a retromastoid to infraclavicular approach: a technical report. Stereotact Funct Neurosurg. 2010; 88(2): 121–5.CrossRefGoogle Scholar
19. Picaza, JA, Hunter, SE, Cannon, BW. Pain suppression by peripheral nerve stimulation. Chronic effects of implanted devices. Appl Neurophysiol. 1977; 40(2–4): 223–4.Google Scholar
20. Matharu, MS, Bartsch, T, Ward, N, Frackowiak, RS, Weiner, R, Goadsby, PJ. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain. 2004; 127(Pt 1): 220–30.CrossRefGoogle ScholarPubMed
21. Thimineur, M, De Ridder, D. C2 area neurostimulation: a surgical treatment for fibromyalgia. Pain Med. 2007; 8(8): 639–46.Google Scholar
22. Goadsby, PJ, Bartsch, T, Dodick, DW. Occipital nerve stimulation for headache: mechanisms and efficacy. Headache. 2008; 48(2): 313–18.Google Scholar
23. Slavin, KV. Peripheral nerve stimulation for the treatment of neuropathic craniofacial pain. Acta Neurochir. Suppl. 2007; 97(Pt 1): 115–20.Google Scholar
24. Reed, KL, Black, SB, Banta, CJ, Will, KR. Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: initial experience. Cephalalgia. 2010; 30(3): 260–71.Google Scholar